Artificial intelligence is gaining more and more attention in the healthcare sector. There are now a variety of applications for AI in healthcare, healthcare organizations, and the life sciences, and the number and complexity of applications is increasing. For example, AI has been applied to new drug discovery, genetic sequencing, medical image recognition, surgery, and many other areas, with AI becoming the key engine behind the analysis, insight, and decision-making processes that lead to more effective healthcare delivery and operational management. In a vision of the future, AI will cover many more areas, including consumer-centric interactive data, monitoring population health, prevention-oriented healthcare services, personalized design of pharmaceuticals and medical devices, disease-assisted diagnosis, customized personalized treatment plans, and more.

To discuss the development of artificial intelligence in the healthcare industry, Harvard China Health Association invited Dr. Dai Han, Head of Bioinvestment at Viva Biotech, Becky Malia, Director of the Healthcare Analytics team at GlaxoSmithKline in the US, and Andreas, CEO of the startup Corti.ai, who shared with us the application of artificial intelligence in healthcare from different perspectives.